- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02752399
Six Minutes Walk Test and Shuttle Walk Test in Eisenmenger Syndrome
April 22, 2016 updated by: Bruna Caroline Matos Garcia, Federal University of São Paulo
Applicability of the Six Minutes Walk Test and Shuttle Walk Test and Evaluation of Peripheral and Respiratory Muscle Function, Autonomic Control, Quality of Life and Sleep, Inflammatory Markers and Tissue Perfusion in Eisenmenger Syndrome
The purpose of this study is to verify the applicability Six minutes walk test and Shuttle walk test in assessing functional capacity in patients with Eisenmenger Syndrome.
Patients will undergo three functional tests, being the six-minute walk test, shuttle walk test and cardiopulmonary exercise test on a cycle ergometer, associated with evaluation of metabolic and ventilatory variables and cardiac monitoring throughout the test.
Study Overview
Status
Unknown
Detailed Description
It has seen an increasing number of individuals with congenital heart diseases mainly due to the development of new diagnostic techniques, assessment and treatment, thereby contributing to longer survival.
These individuals that survive to adulthood, many sometimes develop other secondary problems to the underlying pathology, one of Pulmonary Arterial Hypertension.
The Syndrome Eisenmenger is the most advanced form of pulmonary hypertension secondary to congenital heart defects.
It is known that patients with pulmonary hypertension secondary congenital heart disease have marked functional limitation and high risk of death.
Among the various forms of assess exercise capacity, Walk Test Six Minutes (6MWT), Shuttle walking test and Cardiopulmonary Exercise Test are among the most applicable.
Little has been studied about the patients with pulmonary hypertension secondary to congenital heart disease and Eisenmenger Syndrome.
The characterization of this profile of patients against the effort becomes necessary and useful in determining strategies and identification of factors that may be limited to functional capacity and quality of life.
Objectives: To verify the applicability Six minutes walk test and Shuttle walk test in assessing functional capacity in patients with Eisenmenger Syndrome.
Methods: Cross-sectional study with patients diagnosed with Eisenmenger Syndrome, of both sexes, without changing pace or lower limbs, who have performed echocardiography in the last 6 months and clinical stability.
Patients will undergo three functional tests, being the six-minute walk test, shuttle walk test and cardiopulmonary exercise test on a cycle ergometer, associated with evaluation of metabolic and ventilatory variables and cardiac monitoring throughout the test.
Also will be held assess respiratory endurance and strength, peripheral muscle strength and manual pinch, Heart rate variability, inflammatory mediators and blood lactate, besides questionnaires about quality of life, quality of sleep and daytime drowsiness.
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil, 04021-001
- Recruiting
- Universidade Federal de Sao Paulo
-
Contact:
- Bruna C Matos Garcia
- Phone Number: (+5512) 981254979
- Email: brunacaroline_fisio@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with eisenmenger syndrome that do ambulatory monitoring of congenital heart of Federal University of São Paulo.
Description
Inclusion Criteria:
- Diagnosis of Eisenmenger syndrome
- To understand the realization of tests
- That do ambulatory monitoring of congenital heart of Federal University of São Paulo..
Exclusion Criteria:
- Donw Syndrome
- Changing pace or lower limbs
- Neuromuscular disease
- Pulmonary Obstructive disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Six minute walk test to measure functional capacity in eisenmenger syndrome
Time Frame: One day
|
Six minute walk test will be done with metabolic and ventilatory monitoring and Compared to the cardiopulmonary exercise testing variables , seeing your similarity and if this first test is applicable to measurement functional capacity in Eisenmenger syndrome
|
One day
|
|
Shuttle walk test to measure functional capacity in Eisenmenger syndrome
Time Frame: One day
|
Shuttle walk test will be done with metabolic and ventilatory monitoring and Compared to the cardiopulmonary exercise testing variables , seeing your similarity and if this first test is applicable to measurement functional capacity in Eisenmenger syndrome
|
One day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygen uptake kinetics during six minute walk test in Eisenmenger syndrome
Time Frame: one day
|
Six minute walk test will be done with metabolic and ventilatory monitoring and we will go evaluate behavior of oxygen uptake kinetics in Eisenmenger Syndrome
|
one day
|
|
Correlation between Functional capacity evaluate with six minute walk test and respiratory function evaluate with manovacuometry, spirometry and muscular respiratory endurance.
Time Frame: one day
|
one day
|
|
|
Correlation between Functional capacity evaluate with six minute walk test and peripheric muscular function, evaluate with quadriceps dynamometry and strength of handgrip
Time Frame: one day
|
one day
|
|
|
Correlation between Functional capacity evaluate with six minute walk test and autonomic function, evaluate with cardiofrequency
Time Frame: one day
|
one day
|
|
|
Correlation between Functional capacity evaluate with six minute walk test and life quality evaluate with SF-36 health survey questionnaire
Time Frame: one day
|
one day
|
|
|
Correlation between Functional capacity evaluate with six minute walk test and sleep quality, evaluate with pittsburgh questionnaire for sleep and Epworth Sleepiness Scale
Time Frame: one day
|
one day
|
|
|
Correlation between Functional capacity evaluate with six minute walk test and blood inflammatory mediators and blood lactate
Time Frame: one day
|
one day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Solange Guizilini, mastermind, Federal University of São Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Anticipated)
December 1, 2016
Study Completion (Anticipated)
June 1, 2017
Study Registration Dates
First Submitted
April 18, 2016
First Submitted That Met QC Criteria
April 22, 2016
First Posted (Estimate)
April 27, 2016
Study Record Updates
Last Update Posted (Estimate)
April 27, 2016
Last Update Submitted That Met QC Criteria
April 22, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1.462.879
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.